Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes

<p>This research programme investigated the expression of prolyl hydroxylase (PHD) proteins in rodent tissues. The importance of PHD enzymes lies in their ability to render oxygen sensitivity to Hypoxia inducible factor (HIF), the principal mediator of intracellular oxygen homeostasis. The fir...

ver descrição completa

Detalhes bibliográficos
Autor principal:	Wijeyekoon, JB
Outros Autores:	Pugh, C
Formato:	Tese
Idioma:	English
Publicado em:	2013
Assuntos:	Medical Sciences Clinical laboratory sciences

Registros relacionados

Regulation of HIF: prolyl hydroxylases.
por: Stolze, I, et al.
Publicado em: (2006)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
por: Chowdhury, R, et al.
Publicado em: (2016)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
por: Rasheduzzaman Chowdhury, et al.
Publicado em: (2016-08-01)

Tolerance in renal transplantation: is mixed chimerism the missing link?
por: Janes, S, et al.
Publicado em: (2009)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
por: McNeill, L, et al.
Publicado em: (2002)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
por: Tuckerman, JR, et al.
Publicado em: (2004)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
por: Mole, D, et al.
Publicado em: (2003)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
por: Schlemminger, I, et al.
Publicado em: (2003)

Studies on HIF hydroxylases
por: Webb, J
Publicado em: (2008)

Cortical dynamics subserving visual apparent motion
por: Ahmed, B, et al.
Publicado em: (2008)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
por: Moritz J. Strowitzki, et al.
Publicado em: (2021-04-01)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
por: Holt-Martyn, JP, et al.
Publicado em: (2019)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
por: Cockman, M, et al.
Publicado em: (2019)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
por: Matthew E Cockman, et al.
Publicado em: (2019-09-01)

Prolyl hydroxylase domain enzyme PHD2 inhibits proliferation and metabolism in non-small cell lung cancer cells in HIF-dependent and HIF-independent manners
por: Hongyan Deng, et al.
Publicado em: (2024-06-01)

The role of CCL25 and CCR9 in intestinal inflammation
por: Wendt, E, et al.
Publicado em: (2013)

Adaptive changes of influenza virus A/H5N1 neuraminidase in vitro and in vivo
por: Le Nguyen, T
Publicado em: (2014)

Angiogenesis in human lung tumours
por: Ferguson, ML
Publicado em: (2008)

Editorial commentary: Understanding BCG is the key to improving it
por: McShane, H
Publicado em: (2014)

Human T-lymphotropic virus type 1(HTLV-1) associated infective dermatitis
por: Hlela, C
Publicado em: (2011)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
por: Chan, M, et al.
Publicado em: (2016)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
por: Yeh, TL, et al.
Publicado em: (2017)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
por: Maria Savyuk, et al.
Publicado em: (2020-07-01)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
por: Andrey A. Poloznikov, et al.
Publicado em: (2021-01-01)

Novel and selective small molecule inhibitors and activators for the prolyl hydroxylase domain enzyme
por: Holt-Martyn, J
Publicado em: (2018)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
por: Flashman, E, et al.
Publicado em: (2010)

Probing the molecular basis of melanopsin induced light sensitivity
por: Vachtsevanos, AN
Publicado em: (2012)

Therapeutic Effect of Extracellular Vesicles Derived from HIF Prolyl Hydroxylase Domain Enzyme Inhibitor-Treated Cells on Renal Ischemia/Reperfusion Injury
por: Zhao-Ying Ding, et al.
Publicado em: (2022-03-01)

HR23B, a biomarker for HDAC inhibitors
por: Khan, OA
Publicado em: (2013)

Risk factors for haemorrhage in patients with haematological malignancies
por: Estcourt, LJ
Publicado em: (2014)

Transcription regulation of Nrp1 during endothelial cell differentiation
por: Zhao, Z
Publicado em: (2014)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
por: Chowdhury, R, et al.
Publicado em: (2013)

Structural, biochemical and inhibition studies on hypoxia-inducible factor (HIF) prolyl hydroxylases
por: Lippl, K
Publicado em: (2018)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
por: Masson, N, et al.
Publicado em: (2003)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
por: Takahiro Kambara, et al.
Publicado em: (2024-03-01)

HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
por: Kiichi Hirota
Publicado em: (2021-04-01)

The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer
por: Kilian B. Kennel, et al.
Publicado em: (2022-11-01)

Network activity in primary hippocampal cultures upon HIF-prolyl hydroxylase inhibition
por: Savyuk, Maria Olegovna, et al.
Publicado em: (2021-05-01)

Evaluation of strain circulation and the epidemiology of enteric fever caused
por: Karkey, A, et al.
Publicado em: (2012)

International best practice: Understanding the core difference between medical laboratory science and clinical laboratory medicine in Nigeria
por: Felix Archibong, et al.
Publicado em: (2021-01-01)